Patents Assigned to BAYER PHARMA ATKIENGESELLSCHAFT
  • Publication number: 20220193085
    Abstract: Methods of thromboprophylaxis using rivaroxaban is provided for children with congenital heart disease post-Fontan procedure.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Applicants: JANSSEN PHARMACEUTICALS, INC., BAYER PHARMA ATKIENGESELLSCHAFT
    Inventors: CHRISTOPHER NESSEL, Stefan Willmann, Dagmar Kubitza, Roger M. Mills, Catherine Vanden Boom, Elliot Barnathan, Liza Miriam Pina